Levophenacylmorphan
- Level
- Commodity
- Parent
- 51372000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51372011This classification denotes an opioid receptor agonist with the molecular formula C24H27NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7Q24AL2BR2, chemically known as morphinan-3-ol, 17-(2-oxo-2-phenylethyl)- but generally known as levophenacylmorphan, which bears US NIH Compound Identifier 517743. European Medicines Agency schedules Levophenacylmorphan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08484MIG. The term LEVOPHENACYLMORPHAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). LEVOPHENACYLMORPHAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule levophenacylmorphan under HS 29334990 and SITC 51575. As of Q4 2014, LEVOPHENACYLMORPHAN remains the US FDA Preferred Term for this commodity. Levophenacylmorphan bears US NLM identifiers UMLS ID C2827237 and NCI Concept Code C83880. SMILES: OC1CC2C34C(C(N(CC3)CC(=O)C3CCCCC3)CC2CC1)CCCC4.
Same parent
Under 51372000 · 42Activities that produce or sell this
KBLI · 8Inherited from family 51370000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.